Home > Cashflow Statement > CIPLA

CIPLA
Cashflow Statement

CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹6,821 Cr₹5,897 Cr₹4,221 Cr₹3,675 Cr₹3,290 Cr
Adjustment ₹518 Cr₹641 Cr₹878 Cr₹967 Cr₹1,131 Cr
Changes In working Capital ₹-665 Cr₹-806 Cr₹-559 Cr₹-177 Cr₹372 Cr
Cash Flow after changes in Working Capital ₹6,673 Cr₹5,731 Cr₹4,540 Cr₹4,465 Cr₹4,793 Cr
Cash Flow from Operating Activities ₹5,005 Cr₹4,134 Cr₹3,238 Cr₹3,326 Cr₹3,755 Cr
Cash Flow from Investing Activities ₹-3,691 Cr₹-2,988 Cr₹-2,389 Cr₹-1,872 Cr₹-2,387 Cr
Cash Flow from Financing Activities ₹-1,293 Cr₹-1,200 Cr₹-958 Cr₹-1,600 Cr₹-1,240 Cr
Net Cash Inflow / Outflow ₹21 Cr₹-55 Cr₹-109 Cr₹-146 Cr₹129 Cr
Opening Cash & Cash Equivalents ₹512 Cr₹561 Cr₹658 Cr₹790 Cr₹649 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹9.26 Cr₹5.56 Cr₹12 Cr₹13 Cr₹13 Cr
Closing Cash & Cash Equivalent ₹543 Cr₹512 Cr₹561 Cr₹658 Cr₹790 Cr

Compare Cashflow Statement of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹122,260.5 Cr 0.5% 1.6% 1.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,284.0 Cr -0% -0.4% 10.2% Stock Analytics
DIVIS LABORATORIES ₹183,268.0 Cr 1.4% 4.1% 50.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹113,988.0 Cr -1.2% 7.1% 18.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,921.0 Cr 1.7% 1.2% 1.5% Stock Analytics
MANKIND PHARMA ₹100,677.0 Cr 5% 3.3% 11% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

0.5%

1.6%

1.4%

SENSEX

-0.7%

3%

5%


You may also like the below Video Courses